Explore KMT2A/MLL gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Introcelluar Protein.
This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
| Target ID |
GM-T25462
|
| Target Name |
KMT2A/MLL
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
4297
|
| Gene ID |
100071238 (Equus caballus), 101090288 (Felis catus), 214162 (Mus musculus), 315606 (Rattus norvegicus) 4297 (Homo sapiens), 479417 (Canis lupus familiaris), 508330 (Bos taurus), 705511 (Macaca mulatta)
|
| Target Alternative Names |
6430520K01,ALL-1,ALL1,All1,CXXC-type zinc finger protein 7,CXXC7,Cxxc7,Cysteine methyltransferase KMT2A,GAS7,HRX,HTRX,HTRX1,Histone-lysine N-methyltransferase 2A,KMT2A,Kmt2a,Lysine N-methyltransferase 2A,MLL,MLL1,MLL1A,Mll,Mll1,Myeloid/lymphoid or mixed-lineage leukemia,Myeloid/lymphoid or mixed-lineage leukemia protein 1,TRX1,Trithorax-like protein,WDSTS,Zinc finger protein HRX,all-1,mKIAA4050
|
| Uniprot Accession |
P55200,Q03164
|
| Protein Sub-location |
Introcelluar Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer
|
| Disease from KEGG |
Metabolic pathways, Cushing syndrome
|
| Gene Ensembl |
ENSECAG00000007743, ENSMUSG00000002028, ENSG00000118058, ENSCAFG00845002141, ENSBTAG00000018093, ENSMMUG00000005482
|
| Target Classification |
Tumor-associated antigen (TAA)
|
KMT2A/MLL siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo4297 | Pre-made Human KMT2A/HRX/MLL siRNA oligo Duplex | 4297 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo315606 | Pre-made Rat Kmt2a/Mll/Mll1 siRNA oligo Duplex | 315606 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo214162 | Pre-made Mouse Kmt2a/HRX/Mll siRNA oligo Duplex | 214162 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo705511 | Pre-made Cynomolgus/Rhesus macaque KMT2A/MLL/all-1 siRNA oligo Duplex | 705511 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101090288 | Pre-made Cat/Feline KMT2A/MLL siRNA oligo Duplex | 101090288 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo479417 | Pre-made Dog/Canine KMT2A/MLL siRNA oligo Duplex | 479417 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo508330 | Pre-made Bovines/Cattle KMT2A/MLL siRNA oligo Duplex | 508330 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100071238 | Pre-made Equine/Horse KMT2A siRNA oligo Duplex | 100071238 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
KMT2A/MLL antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T25462-Ab | Human | Anti-Human KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-rg-T25462-Ab | Rat | Anti-Rat KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-mg-T25462-Ab | Mouse | Anti-Mouse KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T25462-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-felg-T25462-Ab | Cat/Feline | Anti-Cat/Feline KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-cang-T25462-Ab | Dog/Canine | Anti-Dog/Canine KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T25462-Ab | Bovines/Cattle | Anti-Bovines/Cattle KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
| GM-Tg-equg-T25462-Ab | Equine/Horse | Anti-Equine/Horse KMT2A/MLL monoclonal antibody | mab | Therapeutics Target antibody | Detail |
KMT2A/MLL recombinant protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T25462-Ag | Human | Human KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-rg-T25462-Ag | Rat | Rat KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-mg-T25462-Ag | Mouse | Mouse KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-cynog-T25462-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-felg-T25462-Ag | Cat/Feline | Cat/Feline KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-cang-T25462-Ag | Dog/Canine | Dog/Canine KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-bovg-T25462-Ag | Bovines/Cattle | Bovines/Cattle KMT2A/MLL recombinant protein | Mammalian cell | Detail |
| GM-Tg-equg-T25462-Ag | Equine/Horse | Equine/Horse KMT2A/MLL recombinant protein | Mammalian cell | Detail |